TrialJAMA network open2023

Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer: A Randomized Clinical Trial.

Peng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.